Argyris Dritselis
Overview
Explore the profile of Argyris Dritselis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
159
Followers
0
Related Specialty
Related Specialty
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vincenti F, Dritselis A, Kirkpatrick P
Nat Rev Drug Discov
. 2011 Sep;
10(9):655-6.
PMID: 21878974
No abstract available.
2.
Grunfeld C, Dritselis A, Kirkpatrick P
Nat Rev Drug Discov
. 2011 Feb;
10(2):95-6.
PMID: 21283099
In November 2010, tesamorelin (Egrifta; Theratechnologies/EMD Serono), a growth hormone-releasing factor analogue, was approved by the US Food and Drug Administration for the reduction of excess abdominal fat in HIV-infected...
3.
Galsky M, Dritselis A, Kirkpatrick P, Oh W
Nat Rev Drug Discov
. 2010 Sep;
9(9):677-8.
PMID: 20811375
No abstract available.
4.
Drucker D, Dritselis A, Kirkpatrick P
Nat Rev Drug Discov
. 2010 Apr;
9(4):267-8.
PMID: 20357801
In January 2010, liraglutide (Victoza; Novo Nordisk)--an injectable glucagon-like peptide 1 receptor agonist--was approved by the US FDA to improve glycaemic control in adults with type 2 diabetes mellitus.
5.
Keating M, Dritselis A, Yasothan U, Kirkpatrick P
Nat Rev Drug Discov
. 2010 Feb;
9(2):101-2.
PMID: 20118960
No abstract available.
6.
Meltzer H, Dritselis A, Yasothan U, Kirkpatrick P
Nat Rev Drug Discov
. 2009 Oct;
8(11):843-4.
PMID: 19876039
In August 2009, asenapine (Saphris; Schering-Plough) was approved by the US FDA for the acute treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adults.